EVMN Operating Cash Flow (Statement)
Evommune, Inc. Common Stock · Operating Cash Flow (Statement)
EVMN Operating Cash Flow (Statement)
Latest reported-$20.32Mperiod ending
EVMN Quarterly Cash from Operations (-$4.83M → -$20.32M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
EVMN operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -20,316,000 | |
| -27,503,000 | |
| -16,699,000 | |
| -9,635,000 | |
| -26,208,000 | |
| -23,899,000 | |
| -18,512,000 | |
| -26,227,000 | |
| -8,626,000 | |
| -4,830,000 |